Home > Healthcare > Pharmaceuticals > Finished Drug Form > Physiological Saline Market
Physiological Saline Market size accounted for USD 5.3 billion in 2022 and is estimated to grow at 6.2% to reach USD 9.6 billion by 2032. The increasing prevalence of chronic diseases requiring intravenous therapies, such as cancer, diabetes, and cardiovascular conditions, fuels the demand for saline solutions.
The aging population and a rise in surgical procedures contribute to the need for sterile saline for wound irrigation and hydration. Also, advancements in medical technology and the expanding healthcare infrastructure promote the usage of saline in various medical settings. Furthermore, the ongoing focus on patient safety and infection control drives the demand for sterile solutions like saline, in turn propelling the adoption across all geographies.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Physiological Saline Market Size in 2022: | USD 5.3 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 6.2% |
2032 Value Projection: | USD 9.6 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 213 |
Segments covered: | Type, Packaging Type, Application, End-user, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Physiological saline is a sterile solution that closely resembles the composition of bodily fluids, particularly extracellular fluid. It is composed of 0.9% sodium chloride (NaCl) dissolved in water, making it isotonic and compatible with the body's physiological conditions. Physiological saline is commonly used in medical and healthcare settings for various purposes, including intravenous fluid replacement, hydration therapy, medication administration, and wound irrigation. It serves as a source of electrolytes and helps maintain fluid balance in the body.